215 related articles for article (PubMed ID: 37978492)
1. Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.
Crapo JD; Gupta A; Lynch DA; Turner AM; Mroz RM; Janssens W; Ludwig-Sengpiel A; Koegler H; Eleftheraki A; Risse F; Diefenbach C
Respir Res; 2023 Nov; 24(1):290. PubMed ID: 37978492
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
Zhang J; Lin XF; Bai CX
Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
[TBL] [Abstract][Full Text] [Related]
3. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
[TBL] [Abstract][Full Text] [Related]
4. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
5. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary
Lessard E; Young HM; Bhalla A; Pike D; Sheikh K; McCormack DG; Ouriadov A; Parraga G
Acad Radiol; 2017 Nov; 24(11):1402-1411. PubMed ID: 28645458
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative analysis of emphysema and air trapping at inspiratory and expiratory phase multi-slice spiral CT scan in smokers: correlation with pulmonary function test].
Zhang D; Guan Y; Fan L; Xia Y; Liu SY
Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1467-1473. PubMed ID: 29804412
[No Abstract] [Full Text] [Related]
8. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
[TBL] [Abstract][Full Text] [Related]
9. FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD.
Crapo J; Gupta A; Lynch DA; Vogel-Claussen J; Watz H; Turner AM; Mroz RM; Janssens W; Ludwig-Sengpiel A; Beck M; Langellier B; Ittrich C; Risse F; Diefenbach C
BMJ Open; 2021 Mar; 11(3):e042526. PubMed ID: 33753437
[TBL] [Abstract][Full Text] [Related]
10. Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document.
Suzuki T; Tada Y; Kawata N; Ikari J; Kasahara Y; Sakurai Y; Iesato K; Nishimura R; West J; Tatsumi K
Int J Chron Obstruct Pulmon Dis; 2015; 10():1199-205. PubMed ID: 26150711
[TBL] [Abstract][Full Text] [Related]
11. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
13. Stronger Associations of Centrilobular Than Paraseptal Emphysema With Longitudinal Changes in Diffusing Capacity and Mortality in COPD.
Shiraishi Y; Tanabe N; Shimizu K; Oguma A; Shima H; Sakamoto R; Yamazaki H; Oguma T; Sato A; Suzuki M; Makita H; Muro S; Nishimura M; Sato S; Konno S; Hirai T
Chest; 2023 Aug; 164(2):327-338. PubMed ID: 36736486
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
Capaldi DP; Zha N; Guo F; Pike D; McCormack DG; Kirby M; Parraga G
Radiology; 2016 May; 279(2):597-608. PubMed ID: 26744928
[TBL] [Abstract][Full Text] [Related]
15. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
[TBL] [Abstract][Full Text] [Related]
16. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
17. Pulmonary Imaging Phenotypes of Chronic Obstructive Pulmonary Disease Using Multiparametric Response Maps.
MacNeil JL; Capaldi DPI; Westcott AR; Eddy RL; Barker AL; McCormack DG; Kirby M; Parraga G
Radiology; 2020 Apr; 295(1):227-236. PubMed ID: 32096708
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
19. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
20. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
